You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 6, Dec 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (325)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gram-Negative Bacteremia

II. Clinical, Laboratory, and Therapeutic Observations

WILLIAM R. McCABE, M.D.; GEORGE GEE JACKSON, M.D.

Arch Intern Med. 1962;110(6):856-864.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The increasing frequency of Gram-negative bacteremia, its ecology, and the importance of host factors in its outcome were emphasized in a preceding paper which reviewed the occurrence of these infections during an 8-year period at the University of Illinois Hospitals.1 The severe, often rapidly fatal nature of Gram-negative bacteremia, especially in patients with important underlying diseases, makes prompt recognition highly desirable for the early institution of optimal therapy. Certain features of the syndrome permit its clinical recognition and differentiation from other hospital-acquired infections. Most authors have emphasized the occurrence, therapy, or individual factors other than diagnostic clinical features. The present report describes the clinical manifestations, biochemical alterations, and treatment of 173 patients with Gram-negative bacteremia. Evaluation of the use of antibiotics, corticosteroids, and vasopressors included consideration of the nature and severity of the patient's underlying illness which we have shown to exert a profound effect on the outcome of . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

Formerly Research Fellow in Infectious Diseases, Research and Educational Hospitals; Clinical Investigator, Veterans Administration West Side Hospital; Instructor in Medicine, University of Illinois College of Medicine (Dr. McCabe); Professor of Medicine, University of Illinois College of Medicine (Dr. Jackson).; From the Department of Medicine, Research and Educational Hospitals, University of Illinois College of Medicine.


Footnotes

Submitted for publication May 22, 1962; accepted July 5.

These studies were supported in part by a grant, No. E1949, from the U.S. Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.